These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


482 related items for PubMed ID: 18172322

  • 1. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
    Degl'Innocenti E, Grioni M, Capuano G, Jachetti E, Freschi M, Bertilaccio MT, Hess-Michelini R, Doglioni C, Bellone M.
    Cancer Res; 2008 Jan 01; 68(1):292-300. PubMed ID: 18172322
    [Abstract] [Full Text] [Related]

  • 2. Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization.
    Degl'Innocenti E, Grioni M, Boni A, Camporeale A, Bertilaccio MT, Freschi M, Monno A, Arcelloni C, Greenberg NM, Bellone M.
    Eur J Immunol; 2005 Jan 01; 35(1):66-75. PubMed ID: 15597325
    [Abstract] [Full Text] [Related]

  • 3. Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice.
    Chiu BC, Stolberg VR, Zhang H, Chensue SW.
    Mech Ageing Dev; 2007 Jan 01; 128(11-12):618-27. PubMed ID: 17961632
    [Abstract] [Full Text] [Related]

  • 4. Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity.
    Nair S, Boczkowski D, Fassnacht M, Pisetsky D, Gilboa E.
    Cancer Res; 2007 Jan 01; 67(1):371-80. PubMed ID: 17210720
    [Abstract] [Full Text] [Related]

  • 5. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.
    Surgery; 2009 Jun 01; 145(6):663-74. PubMed ID: 19486771
    [Abstract] [Full Text] [Related]

  • 6. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
    Oderup C, Malm H, Ekberg H, Qi Z, Veress B, Ivars F, Corbascio M.
    Transplantation; 2006 Dec 15; 82(11):1493-500. PubMed ID: 17164722
    [Abstract] [Full Text] [Related]

  • 7. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
    Viehl CT, Moore TT, Liyanage UK, Frey DM, Ehlers JP, Eberlein TJ, Goedegebuure PS, Linehan DC.
    Ann Surg Oncol; 2006 Sep 15; 13(9):1252-8. PubMed ID: 16952047
    [Abstract] [Full Text] [Related]

  • 8. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Brandenburg S, Takahashi T, de la Rosa M, Janke M, Karsten G, Muzzulini T, Orinska Z, Bulfone-Paus S, Scheffold A.
    Eur J Immunol; 2008 Jun 15; 38(6):1643-53. PubMed ID: 18493984
    [Abstract] [Full Text] [Related]

  • 9. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
    Klages K, Mayer CT, Lahl K, Loddenkemper C, Teng MW, Ngiow SF, Smyth MJ, Hamann A, Huehn J, Sparwasser T.
    Cancer Res; 2010 Oct 15; 70(20):7788-99. PubMed ID: 20924102
    [Abstract] [Full Text] [Related]

  • 10. Combination of CTL-associated antigen-4 blockade and depletion of CD25 regulatory T cells enhance tumour immunity of dendritic cell-based vaccine in a mouse model of colon cancer.
    Saha A, Chatterjee SK.
    Scand J Immunol; 2010 Feb 15; 71(2):70-82. PubMed ID: 20384858
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M, Kamigaki T, Yamashita K, Hori Y, Hasegawa H, Kuroda D, Moriyama H, Nagata M, Ku Y, Kuroda Y.
    Oncol Rep; 2009 Aug 15; 22(2):337-43. PubMed ID: 19578774
    [Abstract] [Full Text] [Related]

  • 12. Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells.
    Azukizawa H, Döhler A, Kanazawa N, Nayak A, Lipp M, Malissen B, Autenrieth I, Katayama I, Riemann M, Weih F, Berberich-Siebelt F, Lutz MB.
    Eur J Immunol; 2011 May 15; 41(5):1420-34. PubMed ID: 21469094
    [Abstract] [Full Text] [Related]

  • 13. Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61.
    McNeill A, Spittle E, Bäckström BT.
    Scand J Immunol; 2007 Jan 15; 65(1):63-9. PubMed ID: 17212768
    [Abstract] [Full Text] [Related]

  • 14. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM, Rich FJ, Goldsack LM, de Lisle GW, Buddle BM, Delahunt B, Kirman JR.
    Eur J Immunol; 2008 Mar 15; 38(3):695-705. PubMed ID: 18266274
    [Abstract] [Full Text] [Related]

  • 15. Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
    Neeley YC, Arredouani MS, Hollenbeck B, Eng MH, Rubin MA, Sanda MG.
    Prostate; 2008 May 15; 68(7):715-27. PubMed ID: 18302222
    [Abstract] [Full Text] [Related]

  • 16. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice.
    Shima T, Sasaki Y, Itoh M, Nakashima A, Ishii N, Sugamura K, Saito S.
    J Reprod Immunol; 2010 Jun 15; 85(2):121-9. PubMed ID: 20439117
    [Abstract] [Full Text] [Related]

  • 17. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.
    Haematologica; 2008 Mar 15; 93(3):423-30. PubMed ID: 18287134
    [Abstract] [Full Text] [Related]

  • 18. Depleting anti-CD4 monoclonal antibody (GK1.5) treatment: influence on regulatory CD4+CD25+Foxp3+ T cells in mice.
    Yi H, Zhen Y, Zeng C, Zhang L, Zhao Y.
    Transplantation; 2008 Apr 27; 85(8):1167-74. PubMed ID: 18431238
    [Abstract] [Full Text] [Related]

  • 19. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
    Berntsen A, Brimnes MK, thor Straten P, Svane IM.
    J Immunother; 2010 May 27; 33(4):425-34. PubMed ID: 20386464
    [Abstract] [Full Text] [Related]

  • 20. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM, Thompson TC, Old LJ, Wang RF.
    Clin Cancer Res; 2007 Dec 01; 13(23):6947-58. PubMed ID: 18056169
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.